Economics

Updates: Ethical Finance

Mobilized News Weekly Systems Update Ethical Finance Coverage: July 11–18, 2026 Published: July 19, 2026 Core Signal Finance is scaling. The harder task is ensuring that the benefits scale with it. This week brought record multilateral climate financing, a landmark […]
Economics

Transforming Towards: Ethical Finance

What is wrong? Finance is commonly designed around maximizing short-term financial returns rather than supporting human well-being, resilient communities and a healthy planet. Money often flows toward speculation, extraction and concentrated corporate power while essential community needs—including affordable housing, local […]
Economics

Tax Justice

  “Tax is one of the smartest investments you can make.” That’s Professor Chris Harrop’s promise to companies, and his new tax funded impact model proves it by helping quantify how paying tax is not only good for their businesses, but for […]
Investor Relations

The British IR Society Best Practice Awards 2025 Ceremony

The prestigious annual ceremony celebrated the achievements of companies that demonstrate their commitment to ensuring the best possible relationship with investors. The final list of winners is announced here: IR_Society_Winners_2025 Self-entries awards: Best Communication of Sustainability Best Innovation in IR Best Corporate […]
Investor Relations

10th Quam IR Awards Held in Hong Kong

IR7 reports that the 10th Quam IR Awards were held successfully in Hong Kong. The awards recognized the investor relations and sustainability teams. The Quam IR Awards celebrated its 10th anniversary and recognized many outstanding companies. Quam IR established the […]
Investor Relations

Q4 Launches Q, the First IRO Agent™

Q4, Inc., the leading provider of IR Ops software, launches Q, the first AI-powered IRO Agent™—reports IR7 Newswire. Q is changing the paradigm of investor relations by transforming the way investors manage, analyze, and communicate. It is powered by proven […]
Economics

IR in IPOs of biotech companies

IR in IPOs of early-stage biotech companies: from scientific hypothesis to investor trust IPO for biotech startups is a test of trust formed by IR: trust in science, in technology, in the team, in the company’s ability to build transparent, […]